Sarah Stevens

Preclinical Characteristics of the Hepatitis C Virus NS3/4A Protease Inhibitor ITMN-191 (R7227)

Scott D. Seiwert, Steven W. Andrews, Yutong Jiang et al. · Antimicrobial Agents and Chemotherapy · 2008 · 174 citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

The Substitutions L50F, E166A, and L167F in SARS-CoV-2 3CLpro Are Selected by a Protease Inhibitor <i>In Vitro</i> and Confer Resistance To Nirmatrelvir

Dirk Jochmans, Kim Donckers, Antitsa Stoycheva et al. · mBio · 2023 · 170 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +16

Discovery of 4′-Chloromethyl-2′-deoxy-3′,5′-di-<i>O</i>-isobutyryl-2′-fluorocytidine (ALS-8176), A First-in-Class RSV Polymerase Inhibitor for Treatment of Human Respiratory Syncytial Virus Infection

Guangyi Wang, Jérôme Deval, Jin Tae Hong et al. · Journal of Medicinal Chemistry · 2015 · 138 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Molecular Basis for the Selective Inhibition of Respiratory Syncytial Virus RNA Polymerase by 2'-Fluoro-4'-Chloromethyl-Cytidine Triphosphate

Jérôme Deval, Jin Tae Hong, Guangyi Wang et al. · PLoS Pathogens · 2015 · 95 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

Scoring the Life Events Checklist: Comparison of three scoring methods.

Carissa Weis, E. Kate Webb, Sarah Stevens et al. · Psychological Trauma Theory Research Practice and Policy · 2021 · 79 citations · Full text

Medicine, Human Development, Risk Assessment +12